BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32574438)

  • 1. Middle-ear barotrauma after hyperbaric oxygen therapy: a five-year retrospective analysis on 2,610 patients.
    Edinguele WFOP; Barberon B; Poussard J; Thomas E; Reynier JC; Coulange M
    Undersea Hyperb Med; 2020; 47(2):217-228. PubMed ID: 32574438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Middle ear barotrauma during hyperbaric oxygen therapy; a review of occurrences in 5,962 patients.
    Nasole E; Zanon V; Marcolin P; Bosco G
    Undersea Hyperb Med; 2019 Mar-Apr-May; 46(2):101-106. PubMed ID: 31051054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Middle-ear barotrauma after hyperbaric oxygen therapy.
    Bessereau J; Tabah A; Genotelle N; Français A; Coulange M; Annane D
    Undersea Hyperb Med; 2010; 37(4):203-8. PubMed ID: 20737927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Middle ear barotrauma in hyperbaric oxygen therapy.
    Heyboer M; Wojcik SM; Grant WD; Chambers P; Jennings S; Adcock P
    Undersea Hyperb Med; 2014; 41(5):393-7. PubMed ID: 25558548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of middle ear barotrauma with oxymetazoline/fluticasone treatment.
    Millan SB; Hontz-Geisinger CA; Rooks BJ; Wahl AM; Covington DB
    Undersea Hyperb Med; 2021; 48(2):149-152. PubMed ID: 33975404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of middle ear barotrauma in staged versus linear chamber compression during hyperbaric oxygen therapy: a double blinded, randomized controlled trial.
    Ng AWA; Muller R; Orton J
    Undersea Hyperb Med; 2017; 44(2):101-107. PubMed ID: 28777900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of hyperbaric oxygen treatment--retrospective analysis in 2,334 patients.
    hadanny A; Meir O; Bechor Y; Fishlev G; Bergan J; Efrati S
    Undersea Hyperb Med; 2016; 43(2):113-22. PubMed ID: 27265988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of compression rate and slope on the incidence of symptomatic Eustachian tube dysfunction leading to middle ear barotrauma: a Phase I prospective study.
    Varughese L; O'Neill OJ; Marker J; Smykowski E; Dayya D
    Undersea Hyperb Med; 2019 Mar-Apr-May; 46(2):95-100. PubMed ID: 31051053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for preventing middle ear barotrauma in computer-controlled pressurization of monoplace hyperbaric chambers.
    Hwang L; Song M; Lee Y; Shin TM
    Undersea Hyperb Med; 2019 Mar-Apr-May; 46(2):107-116. PubMed ID: 31051055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of total compression time and rate (slope) of compression on the incidence of symptomatic Eustachian tube dysfunction and middle ear barotrauma: a Phase II prospective study.
    O'Neill OJ; Dayya D; Varughese L; Marker JA; Perez L; Dayya M
    Undersea Hyperb Med; 2021; 48(3):209-219. PubMed ID: 34390625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective analysis of independent patient risk factors for middle ear barotrauma in a multiplace hyperbaric chamber.
    Commons KH; Blake DF; Brown LH
    Diving Hyperb Med; 2013 Sep; 43(3):143-7. PubMed ID: 24122189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBO2 and cerebral palsy in children.
    Gottlieb SF; Neubauer RA
    Undersea Hyperb Med; 2007; 34(1):1-3; author reply 6. PubMed ID: 17393933
    [No Abstract]   [Full Text] [Related]  

  • 13. The O'Neill grading system for evaluation of the tympanic membrane: A practical approach for clinical hyperbaric patients.
    O'Neill OJ; Weitzner ED
    Undersea Hyperb Med; 2015; 42(3):265-71. PubMed ID: 26152108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBO2 and cerebral palsy in children.
    Marois P; Vanasse M
    Undersea Hyperb Med; 2007; 34(1):4-6; author reply 6. PubMed ID: 17393934
    [No Abstract]   [Full Text] [Related]  

  • 15. An anti-barotrauma system for preventing barotrauma during hyperbaric oxygen therapy.
    Song M; Hoon SJ; Shin TM
    Undersea Hyperb Med; 2018; 45(1):19-25. PubMed ID: 29571228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proof of concept study using a modified Politzer inflation device as a rescue modality for treating Eustachian tube dysfunction during hyperbaric oxygen treatment in a multiplace (Class A) chamber.
    O'Neill OJ; Smykowski E; Marker JA; Perez L; Gurash S; Sullivan J
    Undersea Hyperb Med; 2019; 46(1):55-61. PubMed ID: 31154685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral neuropathy may increase the risk for asymptomatic otic barotrauma during hyperbaric oxygen therapy: research report.
    Mozdzanowski C; Perdrizet GA
    Undersea Hyperb Med; 2014; 41(4):267-72. PubMed ID: 25109078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Middle ear barotrauma in patients undergoing hyperbaric oxygen therapy.
    Blanshard J; Toma A; Bryson P; Williamson P
    Clin Otolaryngol Allied Sci; 1996 Oct; 21(5):400-3. PubMed ID: 8932942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dried salted plum consumption ameliorates hyperbaric oxygen therapy-induced otalgia severity at the first chamber session: a prospective randomized controlled study.
    Meng FC; Shen CH; Chu CM; Shih CP; Lin HC; Peng CK; Chang SC; Huang KL
    Undersea Hyperb Med; 2017; 44(6):551-557. PubMed ID: 29281192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Middle ear barotrauma associated with hyperbaric oxygenation treatment.
    Igarashi Y; Watanabe Y; Mizukoshi K
    Acta Otolaryngol Suppl; 1993; 504():143-5. PubMed ID: 8470522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.